Weight-bearing running has been shown to downregulate MSTN, thereby promoting the expression of Wnt and β-catenin in the femur of diabetic rats, reducing GSK-3β expression and enhancing T2DM bone metabolism [109]. Here, GSK3B is linked to type 2 diabetes mellitus.